Alto Neuroscience
Price & Volume
Stats
See moreOpen | $20.49 |
Previous Close | $19.98 |
Day Range | $20.49-$22.91 |
52W Range | $1.60-$25.17 |
Market Cap | $654.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.19 |
News
See moreYahoo Finance • 9 days ago
NYSE Content Update: Alto Neuroscience Raises $120 Million to Fund Development of ALTO-207
Yahoo Finance • 21 days ago
Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight
Yahoo Finance • 4 months ago
Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)
Yahoo Finance • 5 months ago
Alto Neuroscience secures $50M in PIPE financing
About
CEO | Dr. Amit Etkin M.D., Ph.D. |
CFO | Mr. Nicholas C. Smith |
Address | 650 Castro Street, Mountain View, CA, United States, 94041 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 68 |
